Company intelligence / Profile preview

Pivot Park Screening Centre

Oss, North Brabant, Netherlands

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Pivot Park Screening Centre provides preclinical drug discovery services (assay development, lab automation, high-throughput and ultra-high-throughput screening, hit validation and early hit-to-lead) for industry and academia; it does not develop its own clinical pipeline but supports external programs across all therapeutic areas[3][6][8].

Modalities: Small molecule
Industry: Drug Discovery Services

Partnerships

European Lead Factory (central screening facility)[6][8]EU-OPENSCREEN (European infrastructure for chemical biology screening)[6]Academic collaborations with Maastricht University Medical Center+, Utrecht University, Radboudumc and others via joint HTS assay development projects[6][8]

Beyond the preview

Go deeper on Pivot Park Screening Centre.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pivot Park Screening Centre.

Explore the full profile